The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Cryoport announced Novartis has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/...
read more
Merck announced the U.S. launch of RENFLEXIS, a biosimilar of the originator biologic medicine Remicade.
read more
Ablynx has entered into a research collaboration and global exclusive licensing agreement with Sanofi initially focused on developing and ...
read more
Zymeworks and Daiichi Sankyo announced the successful achievement of a research milestone for an immuno-oncology bispecific antibody therapeutic ...
read more
Mylan and Biocon announced the ODAC recommended approval of the companies' proposed biosimilar trastuzumab.
read more
Biohaven received a Notice of Allowance from the USPTO for its patent application number 14/385551, which covers prodrugs of the glutamate modulating ...
read more
Amgen announced that the FDA has approved the sBLA for BLINCYTO to include overall survival data from the Phase 3 TOWER study.
read more
Daiichi Sankyo, Max Planck Innovation GmbH, and the Lead Discovery Center GmbH have signed an agreement providing Daiichi Sankyo with the option to ...
read more
Sanofi announced it will acquire Protein Sciences, a privately held vaccines biotechnology company.
read more
Eli Lilly announced the FDA has accepted and filed its NDA for abemaciclib, a cyclin-dependent kinase (CDK)4 & 6 inhibitor, and given the NDA a ...
read more
Alnylam Pharmaceuticals and Sanofi Genzyme announced the initiation of the ATLAS Phase 3 clinical program for fitusiran.
read more
Eli Lilly & Co., Purdue University
Eli Lilly and Company and Purdue University announced a strategic collaboration to conduct life science research.
read more
ViraCyte has been awarded $3.75M from NIH and the FDA to advance its T cell immunotherapies.
read more
Array announced the submission of two NDAs to the FDA to support use of the combination of binimetinib 45 mg twice daily and encorafenib 450 mg once ...
read more
Bristol-Myers Squibb announced a Phase 3 study evaluating Opdivo 3 mg/kg versus Yervoy 10 mg/kg in patients with stage IIIb/c or stage IV melanoma who...
read more